Q&A: Portland’s Gray Optics sees demand for precision components in COVID-19 tests

Founded in 2017, Gray Optics develops advanced imaging technologies and optical systems for biomedical, life sciences and industrial applications.

This year, the Portland company saw a surge in demand from manufacturers of COVID-19 “point-of-care” tests, which provide disease detection and diagnosis within minutes. Test manufacturers have come to Gray Optics asking for customized optical systems that are an integral part of the tests.

The challenge? Many rapid tests rely on fluorescence detection using a lens that must be precisely aligned, with regard to specifications such as field-of-view and depth-of-field, to a digital image sensor. The Gray Optics team designed those precision optical components for manufacturing at scale. Read more

Related Posts

Bar Harbor approves Jackson Lab’s $33M expansion for rare disease research

The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...

22 August 2024

Bigelow lab receives $7 million for algae research, business development

Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...

21 August 2024

Should Maine create a public medical school? UMaine System will study the question

The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...

21 August 2024